Medical specialists are evaluating artificial-intelligence programs linked to mobile-phone dermatoscopy devices to detect skin cancer [1, 2].
This technology could increase the accessibility of early screenings for a disease that sees 1.5 million new global cases annually [4]. By integrating AI with portable hardware, health systems aim to improve public-health outcomes, and potentially secure insurance reimbursement for the procedure [1, 3].
In Madrid, Spain, pilot implementations of these tools are already underway in hospitals [2, 3]. One specific tool utilizing the iPhone requires 23 photographs to assess a single skin lesion [2]. While some reports suggest the AI can detect cancer more effectively than human dermatologists, experts said the tool is a supplement to professional care [3].
Dr. Verónica Rottenberg, a dermatology expert, said the technology is not intended to replace a medical visit. "Esta tecnología no reemplaza la visita al médico ni debe usarse de forma doméstica sin supervisión profesional," Rottenberg said [1].
The push for AI integration comes as clinicians seek better ways to identify various skin malignancies. For example, rare conditions like Kaposi sarcoma manifest as skin spots and have an incidence of three per 100,000 people per year [5].
Currently, the technology remains under clinical trial. Specialists are monitoring the veracity of the AI's results to ensure that the convenience of a smartphone attachment does not compromise diagnostic accuracy [1].
“This tecnología no reemplaza la visita al médico ni debe usarse de forma doméstica sin supervisión profesional.”
The transition of dermatoscopy from bulky clinic equipment to smartphone attachments represents a shift toward decentralized screening. However, the contradiction between clinical reports of AI superiority and expert warnings against home use indicates a tension between technological capability and medical safety. Until insurance coverage is standardized and clinical trials are finalized, these tools will likely remain diagnostic aids for physicians rather than consumer health products.
